Latest Daiichi Sankyo Inc. Stories
Daiichi Sankyo to support and co-sponsor phase 1 Clinical Study MOUNT KISCO, New York, USA, and Tokyo, Japan, April 25, 2013 /PRNewswire/ -- Perosphere Inc. and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that they have entered into a clinical trial agreement under which Daiichi Sankyo will support and co-sponsor a phase 1 clinical study testing the safety, tolerability and effectiveness of PER977 to reverse the anticoagulant activity of edoxaban,...
Acsis turnkey solution will help meet California mandate and federal regulations MARLTON, N.J., April 9, 2013 /PRNewswire/ -- Acsis Inc., the market leader for Enterprise Serialization solutions, today announced Daiichi Sankyo, Inc. selected the Acsis Serialization Management Suite to comply with FDA e-pedigree mandates and other federal regulations. The turnkey solution includes the Acsis proven serialization management solution with best-of-breed vision and printing equipment from...
TOKYO, Oct. 25, 2012 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has completed patient enrolment in the global Hokusai-VTE phase 3 study investigating the once-daily oral factor Xa inhibitor edoxaban for the treatment and prevention of recurrence of venous thromboembolism (VTE) in patients who have had an acute symptomatic deep vein thrombosis (DVT), pulmonary embolism (PE), or both.(1,2 ) Hokusai-VTE is the largest single...
MIAMI, Oct. 23, 2012 /PRNewswire/ -- Daiichi Sankyo, Inc. and Eli Lilly and Company (NYSE: LLY) today announced new results of two retrospective, observational, comparative effectiveness studies of U.S. hospital data comparing rates of readmission for subsequent heart attack and initial hospitalization costs among patients with acute coronary syndromes (ACS) treated with a percutaneous coronary intervention (PCI) and antiplatelet therapy, including Effient(®) (prasugrel) or...
PRINCETON, N.J., Oct. 9, 2012 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has launched the authorized generic cevimeline hydrochloride 30 mg. capsules in the U.S. market, under an agreement with Daiichi Sankyo, Inc. Cevimeline hydrochloride is indicated for the treatment of symptoms of dry mouth associated with Sjogren's syndrome, an autoimmune disorder affecting the moisture-producing glands, and is presently...
INDIANAPOLIS and TOKYO, Aug. 26, 2012 /PRNewswire/ -- Daiichi Sankyo Company, Limited (TSE: 4568) and Eli Lilly and Company (NYSE: LLY) today announced data from the TRILOGY ACS study, a phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in patients with unstable angina (UA) or non-ST elevation myocardial infarction (NSTEMI), who were managed medically without an artery-opening procedure. At 30 months, 13.9 percent of prasugrel patients vs. 16.0 percent of...
PARSIPPANY, N.J. and BETHLEHEM, Pa., June 25, 2012 /PRNewswire/ -- Today, Daiichi Sankyo, Inc. received U.S. Food and Drug Administration (FDA) approval to package product at its first United States-based packaging facility located in Bethlehem, PA. With this approval, the Company expands its global supply chain capability, helping to ensure the supply of medicine to U.S. physicians and their patients. At this time, the 140,000 square foot facility will package some of the...
WASHINGTON and PARSIPPANY, N.J., March 27, 2012 /PRNewswire/ -- Today, chief executives from Daiichi Sankyo joined the National Cherry Blossom Festival and American and Japanese dignitaries in Washington, D.C. to mark the 100(th) anniversary of the gift of cherry trees from Japan to the United States. During the ceremony, a tree was planted, which was grown from cuttings taken from the second generation of the famous cherry trees at the Tidal Basin. A century ago today, then-First...
PARSIPPANY, N.J., March 9, 2012 /PRNewswire/ -- Chef Franklin Becker of the Two Reasons, One Recipe campaign is pleased to name Lorin Cook of Alpine, N.J. the grand prize winner of the Franklin's Family Fixin's Contest in which adults living with type 2 diabetes and/or high LDL cholesterol - or their family, friends or caretakers - were invited to receive a healthy makeover of their traditional family favorites. To view the multimedia assets associated with this release, please...
EAST HANOVER and PARSIPPANY, N.J., Dec. 15, 2011 /PRNewswire/ -- According to the New Jersey Science, Technology, Engineering and Mathematics (STEM) Education Coalition's latest report card, nearly 270,000 new jobs in STEM-related fields will need to be filled by 2018 in the Garden State. While this bodes well for high school and college students who are already considering careers in these areas, how will teachers and schools continue to motivate and ready students who haven't yet...
